Company news
Dexcom, Inc. (NASDAQ:DXCM) news
Every Dexcom, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Dexcom Reports Second Quarter 2026 Financial Results
July 30, 2026
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
July 22, 2026
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes
July 13, 2026
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
July 9, 2026
Dexcom Further Advances Vision of Glucose Biosensing for All
June 23, 2026
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
June 12, 2026
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
June 6, 2026
Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care...
June 4, 2026
Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
June 2, 2026
Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
May 26, 2026
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
May 18, 2026
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
May 14, 2026
Dexcom to Host Investor Day on May 14, 2026
May 5, 2026
Dexcom Reports First Quarter 2026 Financial Results
April 30, 2026
Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, S...
April 29, 2026
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
April 2, 2026
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
March 11, 2026
Dexcom Appoints Rick Osterloh to Board of Directors
February 26, 2026
Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results
February 12, 2026
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
February 5, 2026
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
February 4, 2026
Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.
January 27, 2026
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
January 12, 2026
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
January 7, 2026
Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy
December 4, 2025
GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Par...
November 25, 2025
Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States
November 20, 2025
Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes
November 19, 2025
Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day
November 14, 2025
Carrot Partners with ŌURA and Dexcom to Deliver Deeper Insights and Experiences for Members on Fertility, Family-Building, and Hormonal H...
November 12, 2025
Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)
November 6, 2025
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
October 30, 2025
Dexcom Appoints Euan Ashley to Board of Directors
October 27, 2025
Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.
October 2, 2025
Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025
September 15, 2025
Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day
September 10, 2025
Dexcom Announces Upcoming Conference Presentations
August 26, 2025
FriskaAi and Dexcom Enter CGM Data Integration Agreement
August 13, 2025
ViCentra to Bring Smartphone-Based Closed Loop Therapy to People with Diabetes in Early 2026
August 12, 2025
Garmin announces collaborations with leading brands for Garmin Marathon Series
August 5, 2025
Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program
July 30, 2025
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
July 30, 2025
Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio
July 28, 2025
Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration
July 23, 2025
Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
July 17, 2025
Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time.
July 1, 2025
Saluda Medical Appoints Barry Regan as Chief Executive Officer
June 30, 2025
Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025
June 18, 2025
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
May 13, 2025
Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program
May 1, 2025